Frequently Asked Questions (FAQ)
Basics
A blood stem cell transplant (BSCT) is a medical treatment that replaces unhealthy or damaged blood-forming cells with healthy blood-forming stem cells from the bone marrow, blood stream, or umbilical cord blood. These cells may come from the patient (autologous transplant) or from a donor (allogeneic transplant). After entering the bloodstream, the transplanted cells travel to the bone marrow, where they begin to grow and produce healthy blood cells. A blood stem cell transplant can be a life-saving treatment for people with leukemia, lymphoma, and many other diseases. Before the transplant, patients receive chemotherapy and sometimes radiation therapy to destroy cancer cells or other unhealthy cells and prepare the body to receive the healthy blood stem cells. The healthy cells are then given to the patient through an infusion into the bloodstream.
Related link: About Blood Stem Cell Transplant
Blood-forming cells, also called blood stem cells, can come from three sources:
- Bone marrow: The soft, spongy tissue inside bones.
- Peripheral blood stem cells (PBSC): Blood stem cells circulating in the bloodstream.
- Umbilical cord blood: Blood-stem cells collected from the umbilical cord and placenta after a baby is born. These are not embryonic stem cells.
The transplant doctor chooses the best source based on factors such as:
- The patient's disease
- How severe the disease is
- The patient’s age and overall health
- Whether a closely matched donor is available
- Other treatment options
Meeting with a transplant doctor early can help improve a patient’s chances of a successful outcome.
Related links:
Each year in the U.S., about 18,500 people ages 0 to 74 are diagnosed with a disease that may require a potentially life-saving blood stem cell product (bone marrow, peripheral blood, or cord blood) transplant.
These estimates use 2025 population data, coupled with information from the Surveillance, Epidemiology, and End Results (SEER) Program supported by the National Cancer Institute, to estimate transplant needs by ancestry. The U.S. Census Bureau updates population estimates annually with 2026 demographic data expected to become available in June 2027.
They include the number of people who may need:
- A related allogeneic transplant: Cells donated from a family member
- An unrelated allogeneic transplants: Cells donated from an unrelated adult donor or cord blood unit
| Ancestry* | Estimated need |
|---|---|
| White | 13,380 |
| Hispanic or Latino | 3,790 |
| Black or African American | 2,500 |
| Asian | 1,280 |
| American Indian or Alaska Native | 390 |
| Native Hawaiian or Other Pacific Islander | 60 |
| Estimated annual transplant need* | 18,500 |
* The numbers do not add up to 18,500 because of rounding and because people may self-identify into more than one category, including “other,” “unknown,” or “decline.”
The estimated annual need for blood stem cell transplantation based on the U.S Census population and SEER data.
To learn more about transplant as a treatment option, see About Blood Stem Cell Transplant.
The C.W. Bill Young Cell Transplantation Program registry, also called the NMDP Registry, is a list of adult donor registrants and donated cord blood units. NMDP operates the registry under federal contracts.
There are many reasons why someone who needs a transplant may not receive one.
Sometimes there are medical reasons. For example, the patient may not be healthy enough to receive a transplant. In these cases, the health care team may recommend other treatments or therapies.
Sometimes patients choose not to have a transplant and decide on other treatment options instead.
Other patients face barriers to getting a transplant, such as limited insurance coverage, not having a caregiver to help during treatment and recovery, or not having housing near the transplant center.
The NMDP Patient Support Center has patient navigators who help patients and families in efforts to overcome these barriers.
In the past, some people could not obtain a transplant because they did not have a suitable donor. Today, new research is making transplant safer for people even when using partially matched donors. You may hear the term mismatched unrelated donor.
Because of these advances, almost everyone who needs a blood stem cell transplant now has a donor option.
To help more people obtain a blood stem cell transplant, Congress created the C.W. Bill Young Cell Transplantation Program (CWBYCTP) in 2005 through the Stem Cell Therapeutic and Research Act of 2005.
The CWBYCTP:
- Supports adding blood stem cell sources (adult marrow donor registrants and umbilical cord blood units) to the registry for patient searches
- Supports patients who need a transplant
- Maintains a database that tracks transplant outcomes
- Supports research to improve transplant care and outcomes
Transplant
More than 22,000 transplants were performed in the United States in 2024.*
Numbers of Transplants, by Type
| Number of transplants | Type of transplant |
|---|---|
| 12,177** | Autologous (using the patient’s own cells) |
| 3,756 | Related allogeneic (cells donated by a family member) |
| 6,646 | Unrelated allogeneic (cells donated by a volunteer donor or cord blood unit) and counted toward the number of transplants facilitated by the CWBYCTP. |
*These data include transplants performed from January 1, 2024, to December 31, 2024.
There are natural delays in collecting, validating, and reporting data that result in these data being the year prior to registry data.
**Many U.S. transplant centers voluntarily report autologous transplant data. Because reporting is not required, this number does not include all the autologous transplants performed in the United States.
If you are considering a transplant, it may be helpful to know how many people with your disease received one.
To view the number of transplants performed in the United States and other transplant statistics, see the Transplant Outcomes page.
In general, transplant survival rates are improving for all donor types.
New research is also making transplant safer for people with partially matched donors. You may hear the term mismatched unrelated donor (MMUD). Because of these advances, almost everyone who needs a transplant now has a donor option.
Survival outcomes data estimate how many people with a similar disease are alive after a certain period of time.
This information can help you and your doctor:
- Better understand the likely course of your disease (prognosis).
- Discuss treatment options
- Make informed treatment decisions
Keep in mind that survival outcomes can be affected by many factors, including:
- Patient factors
- Diagnosis and disease status
- Age
- Overall health
- Previous treatments
- Donor factors
- Who donated the cells (the patient, a family member, or an unrelated donor)
- The source of the cells (bone marrow, peripheral blood, or umbilical cord blood)
- How closely the donated cells match the patient
- Other factors
- The number of patients included in the data. Larger datasets can provide more reliable estimates.
- When patients were treated. Treatments continue to improve, so older data may not reflect current outcomes.
The CIBMTR® (Center for International Blood and Marrow Transplant Research®) Summary Slides include survival data for related and unrelated donors (slides 50 – 69).
Please note:
- No two people are the same, and outcomes can vary widely.
- The Health Resources and Services Administration (HRSA) does not diagnose medical conditions, provide medical advice, or endorse specific products or services.
Talk to your doctor if you have questions about your health. To help you prepare for that conversation, see About Blood Stem Cell Transplant.
For more information about how to find the best donor or cord blood unit, visit:
Most transplants that use cells from an unrelated donor or cord blood unit are performed to treat leukemia or lymphoma, including:
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Chronic lymphocytic leukemia (CLL)
- Chronic myeloid leukemia (CML)
- Juvenile myelomonocytic leukemia
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
A transplant may also be used to treat other diseases and conditions, including:
- Blood disorders
- Sickle cell anemia
- Thalassemia
- Inherited immune system disorders
- Severe combined immunodeficiency (SCID)
- Wiskott-Aldrich syndrome
- Inherited metabolic disorders
- Hurler's syndrome
- Leukodystrophies
- Bone marrow failure disorders
- Severe aplastic anemia
- Fanconi anemia
- Other blood and bone marrow diseases
- Myelodysplastic syndromes
- Myeloproliferative disorders
- Multiple myeloma and other plasma disorders
Related links:
Hospitals that perform blood stem cell transplants are called transplant centers. Transplant centers are located across the United States and around the world.
The Transplant Center Directory is a searchable list of transplant centers in the United States.
When choosing a transplant center, consider these questions:
- Does my insurance limit which transplant centers I can utilize?
- Does my doctor recommend a specific transplant center?
- Does the transplant center perform unrelated donor transplants? Some centers only perform autologous or related donor transplants.
- How many transplants has the transplant center performed for people with my disease?
- How many transplants has the transplant center performed for people my age? Some centers specialize in treating adults, while others specialize in treating children.
Related link: Planning for a Transplant
An unrelated donor transplant in the United States can cost from $240,000 to more than $1 million. This estimate includes the transplant and up to 6 months of follow-up care.
Most health insurance plans cover some transplant costs. However, some plans do not cover the cost of searching for a donor, which can range from $10,000 to more than $50,000.
If a donor is a family member, there is a cost to test whether the donor is a match. Some patients use their own cells instead of donor cells. This is called an autologous transplant, and costs are generally lower.
You may also qualify for state or federal programs, such as Medicaid and Medicare. Coverage for transplant-related costs often depends on your diagnosis, your health plan, and where you live.
If you have private insurance, contact your insurance company or employer to learn what your plan covers.
What you pay may depend on:
- Your insurance plan, including deductibles, coinsurance, and out-of- pocket maximum
- Whether you use in-network providers
- Whether donor search and collection costs are covered
Many transplant centers have staff who can help answer financial questions. Your transplant coordinator can help you find someone who can explain:
- Which services are covered
- Your annual out-of-pocket maximum
- Which hospitals and doctors are in your network
- Whether you need preauthorization
For more information about costs, you can:
- Read Planning for a Transplant
- Contact a Patient Navigator at the NMDP Patient Support Center. NMDP is a contractor for the C.W. Bill Young Cell Transplantation Program.
The transplant team will test your blood to learn your human leukocyte antigen (HLA) type. HLA markers are proteins found on most cells in your body.
The team then looks for a donor or cord blood unit with HLA markers that closely match yours.
Because HLA markers are inherited, your transplant team may ask to test your biological siblings, if you have any. They may also search the NMDP Registry for an unrelated donor or cord blood unit.
Finding an adult donor or cord blood unit through the registry of the C.W. Bill Young Cell Transplantation Program, also called the NMDP Registry, can take from a few weeks up to several months.
First, your health care team will take a blood sample to determine your human leukocyte antigens (HLA) type. HLA markers are proteins found on most cells in your body.
The team then conducts a preliminary search of the registry to look for potential donor matches.
A preliminary search can:
- Show how difficult it may be to find a matching donor
- Help your doctor plan your treatment
If the search continues, you will be referred to a transplant center. The transplant center will:
- Conduct a formal search
- Confirm that potential donors are available
- Select the best donor or cord blood unit for you
Related links:
Contact your transplant center coordinator or doctor. They can give you updates on your search and answer questions about the progress.
If you have questions about the general search process, contact the NMDP Patient Support Center. NMDP is a contractor for the C.W. Bill Young Cell Transplantation Program.
After your first transplant consultation, you will usually return to the care of the doctor who referred you. This doctor continues to care for you while a donor search is underway.
During this time, the referring doctor and transplant doctor work closely together to coordinate your care. They:
- Discuss treatment changes that may affect your transplant
- Help avoid treatments that could increase the risk of transplant complications
- Share updates about the donor search
The transplant team cares for you during transplant and recovery process. They also work with your referring doctor to coordinate your long-term care after transplant.
Related link: Physician Resources
Donors and cord blood units are carefully screened and tested before they are added to the registry of the C.W. Bill Young Cell Transplantation Program, also called the NMDP Registry. These steps greatly reduce the risk of infection or disease, but they cannot eliminate the risk completely.
Before they can donate, donors:
- Are tested for infectious diseases, such as HIV and hepatitis
- Answer questions about their health history to help doctors find risks, such as infectious or hereditary diseases
- Have a medical evaluation to look for signs of disease
NMDP, which operates under federal contracts, monitors diseases that can be spread through blood. When new diseases become of public concern, NMDP reviews potential risks.
If a donor shows signs of a disease, they may not be allowed to donate. In some cases, the transplant doctor in consultation with the patient may decide whether the benefits of using the donor outweigh the risks.
Before donating umbilical cord blood, the person giving birth:
- Answers questions to determine their eligibility to donate
- Completes health history forms, including family medical history to help doctors make sure there are no diseases that could be given to the patient
If a cord blood unit is a possible match, every effort is made to contact the donor family. This helps confirm that child’s health has not changed in a way that could affect the transplant.
Every effort is also made to notify recipients if:
- A donor develops a health problem that could affect a patient
- A patient develops a health problem that could be related to the donor
A Donor and Patient Safety Monitoring Committee made up of blood stem cell transplant experts reviews these situations and attempts to follow them until they are resolved.
Learn more about donor medical eligibility guidelines and cord blood donation eligibility.
Protecting the privacy of patients and donors is a priority. NMDP, a HRSA contractor for the C.W. Bill Young Cell Transplantation Program, who operates the registry and collaborates with transplant centers, donor centers, and organizations in other countries, to follow strict confidentiality guidelines to protect everyone involved.
During the first year after transplant, some registries allow anonymous communication between patients and donors.
To learn more about anonymous communications, see Contacting Your Donor.
After the first year, some registries allow direct contact if both the patient and the donor agree and sign consent forms. Other registries do not allow direct contact at any time.
If you received a cord blood transplant, you cannot have any contact with the person who donated the cord blood.
The NMDP Patient Support Center provides free support, information, and resources for transplant patients, caregivers, and families.
The NMDP Patient Support Center team can help you:
- Learn about transplant and the donor search process
- Find a transplant center
- Get answers to your financial or insurance questions
- Connect with other transplant patients and caregivers
- Find and join clinical trials
- Prepare for life after transplant
All services and resources are free. Staff are available Monday through Friday, 8 a.m. to 5 p.m. Central Time.
- Call: 1-888-999-6743
- Email: patientinfo@nmdp.org
Spanish-speaking staff and interpreters are available. If you need information in another language, tell us—in English—which language you speak. Please stay on the line until an interpreter joins the call. This will take 4 to 8 minutes.
Learn more about support and resources for patients.
Learn more about support and resources for caregivers.
Donation
Donors on the registry* may be asked to donate bone marrow or PBSC for a patient who needs a transplant.
Bone marrow donation
- Bone marrow donation is a surgical procedure performed in the hospital.
- You receive anesthesia before the procedure.
- A doctor uses a needle to collect marrow from your pelvic bone.
PBSC donation
- PBSC is a non-surgical procedure performed in an outpatient clinic.
- For 5 consecutive days before donation, you will receive injections of an FDA-approved medication. This medicine increases the number of blood-forming cells in your bloodstream.
- The cells are then collected through a process called apheresis.
- During apheresis, blood is taken from one arm and passed through a machine that separates out the blood-forming cells.
- The remaining blood is returned through a needle in your other arm.
When you join the registry, you agree to donate by either method. The patient's doctor chooses the donation method that is best for the patient.
Learn more about bone marrow and PBSC donation.
*The C.W. Bill Young Cell Transplantation Program registry, also called the NMDP Registry, is a list of potential donors and donated cord blood units. NMDP operates the registry under federal contracts.
PBSC donation has two main steps: receiving injections of an FDA-approved medication (usually filgrastim) and donating your blood stem cells.
- Receive filgrastim injections
Before donation, you will receive a medicine called filgrastim or a similar FDA-approved medication. This medication helps move more blood stem cells from your bone marrow into your bloodstream.- You will receive one injection each day for five days prior to the donation.
- The first injection may be given at a donor center or clinic.
- On days 2 through 4, you may receive injections at home, at work, at a donor center, or at a clinic.
- On day 5, you will receive your final dose and then donate your blood stem cells at a donor center or hospital outpatient unit.
- Donate your stem cells
PBSC donation is done through a process called apheresis, which is similar to donating plasma.- A needle is placed into each arm.
- Blood is taken from one arm and passed through a machine.
- The machine collects blood-forming cells, platelets, and some white blood cells.
- Plasma and red blood cells are returned through the needle in your other arm.
- All tubing and supplies are sterile and used only for your donation.
If only one day for donation is needed, the process may take up to eight hours. If it is a two-day donation, which are typically back-to-back, are needed, each donation may take four to six hours.
Related link: Donating Peripheral Blood Stem Cells (PBSC)
Yes. However, serious side effects are rare. Fewer than 1% of PBSC donors experience any serious side effects.
Some donors need a central line if they do not have suitable veins in their arms. About 20% of women and 3% of men require a central line.
There is a small risk of serious complications from the insertion of a central line. The donor will learn about these risks before the procedure and must give consent before a central line is placed.
Another possible risk is related to filgrastim, the medicine used to increase the number of blood-forming cells in the bloodstream before donation. Filgrastim has been used for many years to treat people with cancer, but less is known about its long-term effects.
NMDP began using filgrastim with donors in the 1990s. Since then, no NMDP donors* have reported long-term complications related to filgrastim.
*The C.W. Bill Young Cell Transplantation Program registry, also called the NMDP Registry, is a list of potential donors and donated cord blood units. NMDP operates the registry under federal contracts.
PBSC donation is considered investigational because NMDP is studying the procedure in a research study reported to the U.S. Food and Drug Administration (FDA). The study looks at how PBSC donation compares with bone marrow donation and how each type of donation affects transplant outcomes.
*The C.W. Bill Young Cell Transplantation Program registry, also called the NMDP Registry, is a list of potential donors and donated cord blood units. NMDP operates the registry under federal contracts.
Bone marrow donation is a surgical procedure performed in an operating room.
The donation will take place at a hospital that partners with NMDP. The hospital may be near the donor’s home, or the donor may need to travel. Travel and other donation-related expenses are covered.
An NMDP Registry* representative will guide the donor through the process and be available on the day of donation.
Hospital stay
- Donors arrive at the hospital on the day of their donation.
- Most donors stay from early morning until late afternoon
- Some hospitals may ask donors to stay overnight.
Anesthesia
- The donor will receive general or regional anesthesia during the procedure.
- With general anesthesia, the donor is asleep during the procedure.
- With regional anesthesia, the donor remains awake, but the area being treated is numbed.
- Most donors receive general anesthesia.
- The average time under anesthesia is less than two hours.
Donation
- Doctors use special needles to collect marrow from both sides of the back of the pelvic bone.
- The procedure usually requires one to four small incisions.
- The incisions do not require stitches.
Recovery
- Hospital staff will watch donors closely until the anesthesia wears off. They will continue to monitor the donor’s health afterwards.
- Most donors go home the same day or the next morning.
- After the donor leaves the hospital, an NMDP representative will check in with him/her regularly and ask about any side effects. Common side effects include:
- Back or hip pain
- Bruising at the collection site
- Headache
- Fatigue
Muscle pain
Most donors return to their normal routine within a few days.
Learn more:
*The C.W. Bill Young Cell Transplantation Program registry, also called the NMDP Registry, is a list of potential donors and donated cord blood units. NMDP operates the registry under federal contracts.
NMDP* is committed to donor safety. However, no medical procedure is completely risk-free.
Nearly all donors feel fully recovered within a few weeks. A small percentage of donors, about 3% (3 out of every 100), experience a serious complication due to anesthesia or injury to a bone, nerve, or muscle in the hip area.
Serious side effects of anesthesia are rare. Common side effects of general anesthesia include sore throat (caused by the breathing tube) or mild nausea and vomiting. Common side effects of regional anesthesia are lower blood pressure and a headache.
NMDP and its centers do everything they can to ensure the safety and well-being of every donor.
To learn more, see Donor Safety and Support.
*The C.W. Bill Young Cell Transplantation Program registry, also called the NMDP Registry, is a list of adult donor registrants and donated cord blood units. NMDP operates the registry under federal contracts.
Donors on the NMDP Registry* are covered by a donor life, disability, and medical insurance policy for complications related to donation.
For your safety, NMDP works with health care organizations and doctors who are experts in transplant care. The donor center team will monitor your health closely and provide care if you experience any side effects.
To learn more, see Donor Safety and Support.
*The C.W. Bill Young Cell Transplantation Program registry, also called the NMDP Registry, is a list of adult donor registrants and donated cord blood units. NMDP operates the registry under federal contracts.
Cord Blood Donation
Deciding whether to donate or store your baby’s cord blood is a personal choice.
After a baby is born, the umbilical cord and placenta are usually thrown away. However, parents may choose to donate or store the blood that remains in the umbilical cord and placenta.
Your options may include:
- Donate cord blood to a public cord blood bank. If the cord blood cannot be used for transplant, it may be used for research or thrown away.
- Store cord blood in a private (family) cord blood bank for potential future use by the family.
- Save cord blood in a public cord blood bank for a sibling with a medical need.
- Donate your cord blood for medical research.
- Discard as medical waste.
To learn more and help make an informed decision, see Options for Umbilical Cord Blood Banking and Donation.
To donate cord blood to a public cord blood bank:
- Tell your doctor or midwife that you want to donate.
Contact a cord blood bank between weeks 28 and 34 of your pregnancy. The cord blood bank will:
- Check whether your delivery hospital accepts cord blood donations.
- Ask questions to see if you are eligible to donate.
You can usually donate if you are:
- Healthy
- Pregnant with one baby (rather than two or more)
To learn more, see Can I Donate Cord Blood?
Find a list of participating hospitals.
Donate your baby’s cord blood after delivery.
Donating cord blood does not change your labor or delivery. Your care and your baby’s care remain the top priority.
No blood is taken from your baby. After birth, the blood left in the umbilical cord and placenta is collected and tested. If the cord blood meets donation standards, it may be stored for patients who need a transplant. It is not stored for your family.
Provide a blood sample after delivery.
Usually, the day after your baby is born, you will be asked to provide a blood sample. The sample is tested for infectious diseases. The blood is taken only from you, not from your baby.
Public cord blood banks work with their participating hospitals and doctors to provide information to expectant parents.
Learn more about:
No. There is no cost to donate cord blood to a public cord blood bank.
You may also choose to store your baby’s cord blood for your family’s use. If you choose this option, you will pay a collection fee and annual storage fees to a private (family) cord blood bank.
If a biological sibling has a medical need, eligible families may be able to collect and store cord blood at little or no cost.
Learn more about:
Most people with leukemia, lymphoma, or other life-threatening diseases can be treated with a cord blood transplant.
A cord blood transplant uses blood-forming cells collected from the umbilical cord and placenta after a baby is born. These are not embryonic stem cells.
Cord blood can be especially useful when:
- There is no suitable adult donor. For most patients, a close match between donor and patient is important. However, studies show that cord blood does not need to match as closely as bone marrow or peripheral blood stem cells for a transplant to be successful.
- A transplant is needed right away. Finding a donor can take weeks or months. Cord blood units have already been collected and stored, and are ready for use.
A doctor will decide whether cord blood is the best option for a patient. However, not all transplant centers perform cord blood transplants.
Learn about:
After you donate cord blood, the cord blood bank tests the donation to see if it meets transplant standards.
If the cord blood qualifies for transplant, it is tissue typed, frozen and stored in a liquid nitrogen freezer at a public cord blood bank, and listed on the registry for patients searching for a match.
To qualify for transplant, the cord blood must:
- Contain enough blood-forming cells
- Meet health history and blood testing requirements for the birthing parent
- Be free from contamination
- Arrive at the cord blood bank in time for processing
Not all cord blood donations meet transplant standards.
If the cord blood cannot be used for transplant, it may be used for research, with the parent’s permission, or thrown away.
The cord blood bank protects your family’s privacy. Names are not shared with patients or transplant centers. The cord blood is listed by a number, not by a name. Personal information is never shared between the donor family and the transplant recipient.
To help more patients get the transplants they need, Congress passed the Stem Cell Therapeutic and Research Act of 2005
These laws support cord blood collection and donation, cord blood transplants, and research.
To learn more about the Stem Cell Acts of 2005 and 2010 and the 2021 Reauthorization, see:
Registry
Each year, approximately 18,500 people ages 0 to 74 years in the United States are diagnosed with a life-threatening disease or illness that may require a potentially life-saving blood stem cell transplant to treat their medical condition. Many of these patients need a donor.
Most patients do not have a fully matched donor in their family. They depend on the NMDP Registry, the registry of the C.W. Bill Young Cell Transplantation Program, to find an unrelated donor or cord blood unit.
Even with millions of registered donors and more than 750,000 donated cord blood units, some patients still have trouble finding a match. Because tissue types are inherited, patients are more likely to match with someone who shares their ancestry.
NMDP works to increase the genetic variability of donors and cord blood units on the registry so that patients can find a match. There is a particular need for donors who are:
- Black or African American
- American Indian or Alaska Native
- Asian
- Native Hawaiian or other Pacific Islander
- Hispanic or Latino
- Multiple ancestries
New research is also making transplants safer for people with partially matched donors. You may hear the term mismatched unrelated donor (MMUD). Because of these advances, almost everyone who needs a blood stem cell transplant now has a donor option, regardless of their ancestry.
Learn more about:
- The Need for More Donors
- The Need for More Cord Blood Donations
- MMUD in NMDP's Donor for All initiative
The NMDP Registry is a list of unrelated donor registrants and donated cord blood units. NMDP operates the registry under federal contracts.
First, you answer some questions online and order a free swab kit. Then, watch for the kit in the mail. It usually arrives in 3-7 days. Follow the steps in the kit to swab your cheeks and return the kit.
Patients need donors who are ages 18 to 60, meet health guidelines, and are willing to donate to any patient in need.
To learn more, see Joining the Registry.
When you join the registry,* you agree to:
- Stay on the registry until your 61st birthday, unless you ask to be removed
- Be available to donate to any patient who matches you
- Respond promptly if you are contacted as a potential match
- Contact NMDP right away if:
- Your contact information changes
- You have a significant change to your health
- You want to be removed from the registry
You can contact NMDP by:
- Updating your contact information online
- Calling 1-800-MARROW-2 (1-800-627-7692)
Donating is always your choice. You can decide not to donate at any time. However, please think carefully about your commitment before joining the registry.
*The C.W. Bill Young Cell Transplantation Program registry, also called the NMDP Registry, is a list of adult donor registrants and donated cord blood units. NMDP operates the registry under federal contracts.
Every person who joins the registry* gives hope to patients who need a transplant. New patient searches begin every day.
You may never be identified as a match. You may be one of several potential matches. Or you could be the only person who can save a patient's life.
Doctors are more likely to select donors ages 18 to 35 because research shows that cells from younger donors often lead to better transplant outcomes.
If you are a potential match, an NMDP representative will contact you. If you agree to donate, you will be asked to complete additional testing to see if you are the best match.
If you are selected as the best donor and choose to donate, NMDP will schedule an information session. During this session, you will learn about the donation process, possible risks and side effects, and the type of donation requested by the patient’s doctor—either a bone marrow donation or cells collected from the blood, called peripheral blood stem cells.
If you decide to continue, you will begin the donation process.
To learn more, see Donate Bone Marrow.
*The C.W. Bill Young Cell Transplantation Program registry, also called the NMDP Registry, is a list of adult donor registrants and donated cord blood units. NMDP operates the registry under federal contracts.
Data
It takes time to collect, review, and analyze data. Researchers must follow patients for a period of time after their transplant before they can report survival outcomes.
For example, the Center-Specific Survival Analysis reports how many people are alive one year after an allogeneic transplant at U.S. transplant centers. To create this report, researchers must:
- Wait at least one year after their transplant
- Collected and verify data
- Analyze the results
- Complete the review and approval process
This process takes about two additional years after the transplant.
Longer-term survival data takes even more time to collect.
For example, to report three-year survival rates, patients must have had the opportunity to be followed for at least three years after their transplant. Researchers then need additional time to collect, verify, and analyze the data before reporting the results. To report three-year survival results in 2026, at least half of the patients included in the analysis must have received their transplant before 2023.
For most diseases, there are not enough patients at a single transplant center to provide reliable survival data.
Many diseases affect fewer than 100 patients each year. Because these patients receive care at more than 200 transplant centers, most centers have only a small number of patients with the same disease. As a result, it is difficult to accurately predict outcomes for a specific disease at any one center.
The Center for International Blood and Marrow Transplant Research (CIBMTR) must also protect patient privacy. For some rare diseases, only one patient may receive a transplant at a particular center. Reporting results for these diseases could make it possible to identify the patient.
Transplant data are reported to the Stem Cell Therapeutic Outcomes Database, a national database that is part of the C.W. Bill Young Cell Transplantation Program. CIBMTR manages the database under a federal contract.